文献速递肝病消化道肿瘤与早癌

环状RNA cSMARCA5抑制肝细胞癌的生长与转移

Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2018-01-31

研究通过RNA测序鉴定cSMARCA5,并在体外和体内评估其在肝细胞癌中的作用。cSMARCA5在肝癌组织中表达降低,与侵袭性特征相关,是肝切除术后总生存和无复发生存的独立危险因素。机制上cSMARCA5通过海绵吸附miR-17-3p和miR-181b-5p促进TIMP3表达,抑制肝癌细胞增殖和迁移。

要点

  • cSMARCA5在肝癌组织中表达降低,与侵袭性特征相关。
  • cSMARCA5是肝切除术后总生存和无复发生存的独立危险因素。
  • cSMARCA5通过海绵吸附miR-17-3p/miR-181b-5p促进TIMP3表达。

核心结论

  • cSMARCA5在肝细胞癌的生长和转移中起重要作用,为环状RNA在肝癌进展中的作用提供了新视角。

研究设计与样本

  • 研究通过RNA测序鉴定cSMARCA5(来源于SMARCA5基因外显子15和16的环状RNA,hsa_circ_0001445),并用定量逆转录PCR验证。
  • 在体外和体内评估cSMARCA5在肝细胞癌进展中的作用。
  • 采用circRNAs体内沉淀、荧光素酶报告基因实验、生物素偶联microRNA捕获和荧光原位杂交评估cSMARCA5与miR-17-3p/miR-181b-5p的相互作用。

主要发现

  • cSMARCA5在肝癌组织中表达较低,受DExH-Box解旋酶9(一种丰富的核RNA解旋酶)调控。
  • cSMARCA5在肝癌中的下调与侵袭性特征显著相关,并作为肝切除术后肝细胞癌患者总生存和无复发生存的独立危险因素。
  • 体内和体外数据表明cSMARCA5抑制肝癌细胞的增殖和迁移。
  • 机制上,cSMARCA5通过海绵吸附miR-17-3p和miR-181b-5p促进TIMP3(一种著名的肿瘤抑制因子)的表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In recent years, circular RNAs (circRNAs) have been shown to have critical regulatory roles in cancer biology. However, the contributions of circRNAs to hepatocellular carcinoma (HCC) remain largely unknown. METHODS: cSMARCA5 (a circRNA derived from exons 15 and 16 of the SMARCA5 gene, hsa_circ_0001445) was identified by RNA-sequencing and validated by quantitative reverse transcription PCR. The role of cSMARCA5 in HCC progression was assessed both in vitro and in vivo. circRNAs in vivo precipitation, luciferase reporter assay, biotin-coupled microRNA capture and fluorescence in situ hybridization were conducted to evaluate the interaction between cSMARCA5 and miR-17-3p/miR-181b-5p. RESULTS: The expression of cSMARCA5 was lower in HCC tissues, because of the regulation of DExH-Box Helicase 9, an abundant nuclear RNA helicase. The downregulation of cSMARCA5 in HCC was significantly correlated with aggressive characteristics and served as an independent risk factor for overall survival and recurrence-free survival in patients with HCC after hepatectomy. Our in vivo and in vitro data indicated that cSMARCA5 inhibits the proliferation and migration of HCC cells. Mechanistically, we found that cSMARCA5 could promote the expression of TIMP3, a well-known tumor suppressor, by sponging miR-17-3p and miR-181b-5p. CONCLUSION: These results reveal an important role of cSMARCA5 in the growth and metastasis of HCC and provide a fresh perspective on circRNAs in HCC progression. LAY SUMMARY: Herein, we studied the role of cSMARCA5, a circular RNA, in hepatocellular carcinoma. Our in vitro and in vivo data showed that cSMARCA5 inhibits the growth and migration of hepatocellular carcinoma cells, making it a potential therapeutic target.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018. PMID: 29378234. doi:10.1016/j.jhep.2018.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。